Journal of Hepatology

Increased survival in patients with hepatic encephalopathy treated with rifaximin-alpha in combination with lactulose: an observational study from UK clinical practice

Jones B I, Berni E R, Poole C D, Jenkins-Jones S, Orr J G, Amlani B, Walsh S, Currie C J. 01 Jan 2020

Journal of Hepatology

P0139 : Patients experiencing repeated episodes of hepatic encephalopathy have increasing risk of death. A post HOC analysis of rifaximin-α open label study data

Bannister Ch A, Conway P, Radwan A, Morgan C L, Berni E R, Currie C J. 01 Apr 2015

Journal of Hepatology

P0168 : The impact on hospital resource utilisation of Rifaximin-α(alpha) for hepatic encephalopathy in routine clinical practice: Real world data from seven UK liver centres

Orr J G, Goel A, Moriarty K, Sinha A, Gordon F H, Dethier A, Dillon J, Patel V, Shawcross D L, Clark K, Richardson P, Preedy H, Aspinall R, Currie C J, Hudson M. 01 Apr 2015

Journal of Hepatology

Mortality Associated with Hepatic Encephalopathy in Patients with Severe Liver Disease

Morgan C L, Jenkins-Jones S, Radwan A, Conway P, Reynolds A, Currie C J. 01 Apr 2014

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services